Clinical Trial Update: A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil [Phase 2]

View source ↗

Summary

A Phase 2 study of PRX-03140 in Alzheimer's disease patients on a stable dose of Donepezil has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)
• PRX-03140

Snippet

Sponsor: Epix Pharmaceuticals, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED